Theranostic radiopharmaceuticals: established agents in current use

The British Journal of Radiology
James R Ballinger

Abstract

Although use of the term "theranostic" is relatively recent, the concept goes back to the earliest days of nuclear medicine, with the use of radioiodine for diagnosis and therapy of benign and malignant thyroid disease being arguably the most successful molecular radiotherapy in history. A diagnostic scan with 123I-, 124I-, or a low activity of 131I-iodide is followed by therapy with high activity 131I-iodide. Similarly, adrenergic tumours such as phaeochromocytoma and neuroblastoma can be imaged with 123I-metaiodobenzylguanidine and treated with 131I-metaiodobenzylguanidine. Bone scintigraphy can be used to select patients with painful bone metastases from prostate cancer who may benefit from treatment with beta- or alpha-particle emitting bone seeking agents, the most recent and successful of which is 223Ra radium chloride. Anti-CD20 monoclonal antibodies can be used to image and treat non-Hodgkins lymphoma, though this has not been as commercially successful as initially predicted. More recently established theranostics include somatostatin receptor targeting peptides for diagnosis and treatment of neuroendocrine tumours with agents such as 68Ga-DOTATATE and 177Lu-DOTATATE, respectively. Finally, agents which target prostate...Continue Reading

References

Jan 1, 1991·European Journal of Nuclear Medicine·W BeckerF Wolf
Jul 2, 1981·The New England Journal of Medicine·J C SissonN W Thompson
Nov 7, 1999·European Journal of Nuclear Medicine·A OtteJ Muller
Oct 5, 2001·European Journal of Nuclear Medicine·D J KwekkeboomE P Krenning
Sep 7, 2002·Seminars in Urologic Oncology·Daniel YaoStanley J Goldsmith
Mar 4, 2005·Journal of Medicinal Chemistry·Mandar V DeshmukhGerd Gemmecker
Apr 2, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A Hagenbeek, V Lewington
May 11, 2005·Clinical Prostate Cancer·D Bruce SodeeGeorge Bakale
Jun 1, 2005·The Lancet Oncology·Ilora G FinlayMike Shelley
Jan 22, 2008·Bioconjugate Chemistry·I VelikyanB Langstrom
Feb 16, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Francesco GiammarileUNKNOWN EANM
Feb 19, 2008·Expert Review of Anticancer Therapy·Michael J Manyak
Jul 24, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Lisa BodeiUNKNOWN European Association of Nuclear Medicine (EANM)
Aug 2, 2008·European Journal of Nuclear Medicine and Molecular Imaging·M LusterUNKNOWN European Association of Nuclear Medicine (EANM)
Nov 3, 2009·Cancer Biotherapy & Radiopharmaceuticals·Ernst J Postema, Alexander J B McEwan
Feb 2, 2010·Seminars in Nuclear Medicine·Stanley J Goldsmith
Dec 7, 1946·Journal of the American Medical Association·S M SEIDLINE OSHRY
Jun 18, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Yuni K DewarajaAnca M Avram
Jul 14, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Marcel P M StokkelMarkus Luster
Apr 13, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Egesta LopciEmilio Bombardieri
May 4, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Niklaus G SchaeferRichard L Wahl
May 31, 2011·Chemical Communications : Chem Comm·David J BerryPhilip J Blower
Aug 10, 2011·Nature Reviews. Endocrinology·Christoph ReinersFrederik A Verburg
May 4, 2012·The New England Journal of Medicine·Martin SchlumbergerUNKNOWN Tumeurs de la Thyroïde Refractaires Network for the Essai Stimulation Ablation Equivalence Trial
May 4, 2012·The New England Journal of Medicine·Ujjal MallickAllan Hackshaw
Jan 11, 2013·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·John A BarrettJohn W Babich
Feb 8, 2013·European Journal of Nuclear Medicine and Molecular Imaging·L BodeiJohn J Zaknun
Jul 19, 2013·The New England Journal of Medicine·C ParkerUNKNOWN ALSYMPCA Investigators
Dec 18, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jayne S WilsonMark N Gaze
Mar 1, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Christian M ZechmannUwe Haberkorn
Jun 12, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Lidia StrigariGlenn Flux
Jul 30, 2014·PloS One·Ada H V Repetto-LlamazaresJostein Dahle
Oct 25, 2014·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Shankar VallabhajosulaStanley J Goldsmith
Nov 21, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Ali Afshar-OromiehUwe Haberkorn
Jun 13, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J A LedermannT Thigpen
Jun 20, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Martina WeineisenHans-Jürgen Wester
Jul 16, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Neeta Pandit-TaskarMichael J Morris
Sep 1, 2015·Nuclear Medicine Review. Central & Eastern Europe·Michał MaurinRenata Mikołajczak

❮ Previous
Next ❯

Citations

Feb 12, 2019·Journal of Labelled Compounds & Radiopharmaceuticals·Petra Kolenc PeitlClemens Decristoforo
Jun 11, 2020·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Thomas BeyerOsama Mawlawi
Dec 26, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·João Franco MachadoJoão D G Correia
Sep 3, 2020·Nanomaterials·Sarkar Siddique, James C L Chow
Oct 23, 2020·Journal of Leukocyte Biology·Miguel MartinAlexandra Bobirca
Jan 13, 2021·Current Oncology Reports·Yasutaka Yamada, Himisha Beltran
Feb 11, 2021·Journal of Drug Targeting·Mohaddeseh SajjadiSiavash Iravani
Oct 17, 2020·Nature Reviews. Disease Primers·Robert E ColemanLuis Costa
Oct 28, 2020·Proceedings of the National Academy of Sciences of the United States of America·Outi KeinänenBrian M Zeglis
Feb 23, 2021·Asian Journal of Pharmaceutical Sciences·Panoraia I SiafakaEvren Atlıhan Gündoğdu
Apr 15, 2021·Proceedings of the National Academy of Sciences of the United States of America·Jacopo MillulSamuele Cazzamalli
Apr 6, 2021·Journal of Labelled Compounds & Radiopharmaceuticals·Zbynek NovyFrantisek Trejtnar
May 1, 2021·International Journal of Molecular Sciences·Nasim VahidfarElisabeth Eppard
Apr 8, 2019·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Michael M Graham, John M Buatti
Jul 3, 2021·International Journal of Molecular Sciences·Marcus MkhatshwaAmanda-Lee Ezra Manicum
Sep 5, 2019·Molecular Pharmaceutics·Outi KeinänenBrian M Zeglis
Dec 4, 2020·Journal of Medicinal Chemistry·Pavel ŠvecMartin Hrubý
Dec 18, 2021·Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association·Kate L ShumwayCharles A Maitz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Related Papers

Wiener medizinische Wochenschrift
Michael Gabriel
OncoTargets and Therapy
Anna YordanovaMarkus Essler
Annals of Oncology : Official Journal of the European Society for Medical Oncology
W J G OyenB Brans
© 2022 Meta ULC. All rights reserved